Additionally, the pharmacological therapy with opioids, benzodiazepnics, and insulin for the treatment of physiological changes (pain, agitation, anxiety, and metabolic disorders) and to minimize external factors such as noise, often contribute to higher mortality rates in the ICU [32]. The gene discussed is INS; the disease is Other metabolic disease.